TRAIL-mediated apoptosis requires NF-kappaB inhibition and the mitochondrial permeability transition in human hepatoma cells (Q44226747)

1 December 2017

TRAIL-mediated apoptosis requires NF-kappaB inhibition and the mitochondrial permeability transition in human hepatoma cells (English)

1 reference

1 December 2017

hepatocellular carcinoma

1 reference

1 reference

Young-Soo Kim

1

1 reference

1 December 2017

Robert F Schwabe

2

1 reference

1 December 2017

Ting Qian

3

1 reference

1 December 2017

John J Lemasters

4

1 reference

1 December 2017

David A Brenner

5

1 reference

1 December 2017

language of work or name

English

0 references

publication date

1 December 2002

1 reference

1 December 2017

1 reference

1 December 2017

36

1 reference

1 December 2017

1498-1508

1 reference

1 December 2017

6

1 reference

The role of NF-kappa B in TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis of melanoma cells

1 December 2017

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840360627

The mitochondrial permeability transition is required for tumor necrosis factor alpha-mediated apoptosis and cytochrome c release

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840360627

CD40 activates NF-kappa B and c-Jun N-terminal kinase and enhances chemokine secretion on activated human hepatic stellate cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840360627

Contribution of the mitochondrial permeability transition to lethal injury after exposure of hepatocytes to t-butylhydroperoxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840360627

Identification and characterization of a new member of the TNF family that induces apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840360627

7 January 2021

The antitumor function of tumor necrosis factor (TNF), I. Therapeutic action of TNF against an established murine sarcoma is indirect, immunologically dependent, and limited by severe toxicity

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840360627

7 January 2021

Lethal effect of the anti-Fas antibody in mice

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840360627

7 January 2021

Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840360627

7 January 2021

Safety and antitumor activity of recombinant soluble Apo2 ligand

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840360627

7 January 2021

Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840360627

7 January 2021

Is TRAIL hepatotoxic?

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840360627

7 January 2021

An antagonist decoy receptor and a death domain-containing receptor for TRAIL

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840360627

7 January 2021

Cloning and characterization of TRAIL-R3, a novel member of the emerging TRAIL receptor family

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840360627

7 January 2021

The novel receptor TRAIL-R4 induces NF-kappaB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840360627

7 January 2021

Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840360627

7 January 2021

Intracellular mechanisms of TRAIL: apoptosis through mitochondrial-dependent and -independent pathways

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840360627

7 January 2021

Inhibition of death receptor signals by cellular FLIP

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840360627

7 January 2021

Intracellular regulation of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human multiple myeloma cells

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840360627

7 January 2021

TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-kappaB

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840360627

7 January 2021

Tumor necrosis factor-related apoptosis-inducing ligand receptors signal NF-kappaB and JNK activation and apoptosis through distinct pathways

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840360627

7 January 2021

NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840360627

7 January 2021

Bcl-XL protects pancreatic adenocarcinoma cells against CD95- and TRAIL-receptor-mediated apoptosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840360627

7 January 2021

NFkappaB prevents apoptosis and liver dysfunction during liver regeneration

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840360627

7 January 2021

The Mitochondrial Permeability Transition Augments Fas-induced Apoptosis in Mouse Hepatocytes

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840360627

7 January 2021

Differential role of I kappa B kinase 1 and 2 in primary rat hepatocytes

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840360627

7 January 2021

IkappaB kinases phosphorylate NF-kappaB p65 subunit on serine 536 in the transactivation domain

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840360627

7 January 2021

A novel cytotoxicity screening assay using a multiwell fluorescence scanner

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840360627

7 January 2021

Chemotherapeutic agents augment TRAIL-induced apoptosis in human hepatocellular carcinoma cell lines

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840360627

7 January 2021

NF-kappaB inducers upregulate cFLIP, a cycloheximide-sensitive inhibitor of death receptor signaling

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840360627

7 January 2021

Phosphatidylinositol 3-kinase/Akt activity regulates c-FLIP expression in tumor cells

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840360627

7 January 2021

Elevated AKT activity protects the prostate cancer cell line LNCaP from TRAIL-induced apoptosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840360627

7 January 2021

The death domain kinase RIP is essential for TRAIL (Apo2L)-induced activation of IkappaB kinase and c-Jun N-terminal kinase

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840360627

7 January 2021

Akt stimulates the transactivation potential of the RelA/p65 Subunit of NF-kappa B through utilization of the Ikappa B kinase and activation of the mitogen-activated protein kinase p38.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840360627

7 January 2021

Mitochondrial control of cell death

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840360627

7 January 2021

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840360627

7 January 2021

Identifiers

DOI

10.1002/HEP.1840360627

1 reference

1 December 2017

1 reference